Literature DB >> 15063313

Crystal structure of 1-deoxy-d-xylulose-5-phosphate reductoisomerase from Zymomonas mobilis at 1.9-A resolution.

Stefano Ricagno1, Sigrid Grolle, Stephanie Bringer-Meyer, Hermann Sahm, Ylva Lindqvist, Gunter Schneider.   

Abstract

1-Deoxy-d-xylulose-5-phosphate reductoisomerase (DXR) is the second enzyme in the non-mevalonate pathway of isoprenoid biosynthesis. The structure of the apo-form of this enzyme from Zymomonas mobilis has been solved and refined to 1.9-A resolution, and that of a binary complex with the co-substrate NADPH to 2.7-A resolution. The subunit of DXR consists of three domains. Residues 1-150 form the NADPH binding domain, which is a variant of the typical dinucleotide-binding fold. The second domain comprises a four-stranded mixed beta-sheet, with three helices flanking the sheet. Most of the putative active site residues are located on this domain. The C-terminal domain (residues 300-386) folds into a four-helix bundle. In solution and in the crystal, the enzyme forms a homo-dimer. The interface between the two monomers is formed predominantly by extension of the sheet in the second domain. The adenosine phosphate moiety of NADPH binds to the nucleotide-binding fold in the canonical way. The adenine ring interacts with the loop after beta1 and with the loops between alpha2 and beta2 and alpha5 and beta5. The nicotinamide ring is disordered in crystals of this binary complex. Comparisons to Escherichia coli DXR show that the two enzymes are very similar in structure, and that the active site architecture is highly conserved. However, there are differences in the recognition of the adenine ring of NADPH in the two enzymes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063313     DOI: 10.1016/j.bbapap.2003.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

Review 1.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

2.  Toward Mycobacterium tuberculosis DXR inhibitor design: homology modeling and molecular dynamics simulations.

Authors:  Nidhi Singh; Mitchell A Avery; Christopher R McCurdy
Journal:  J Comput Aided Mol Des       Date:  2007-09-14       Impact factor: 3.686

Review 3.  Mechanistic aspects of carotenoid biosynthesis.

Authors:  Alexander R Moise; Salim Al-Babili; Eleanore T Wurtzel
Journal:  Chem Rev       Date:  2013-10-31       Impact factor: 60.622

4.  Crystal structure of Brucella abortus deoxyxylulose-5-phosphate reductoisomerase-like (DRL) enzyme involved in isoprenoid biosynthesis.

Authors:  Jordi Pérez-Gil; Bárbara M Calisto; Christoph Behrendt; Thomas Kurz; Ignacio Fita; Manuel Rodríguez-Concepción
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

5.  Inhibition Studies on Enzymes Involved in Isoprenoid Biosynthesis: Focus on Two Potential Drug Targets: DXR and IDI-2 Enzymes.

Authors:  Jérôme de Ruyck; Johan Wouters; C Dale Poulter
Journal:  Curr Enzym Inhib       Date:  2011-07

Review 6.  Biochemistry of the non-mevalonate isoprenoid pathway.

Authors:  Tobias Gräwert; Michael Groll; Felix Rohdich; Adelbert Bacher; Wolfgang Eisenreich
Journal:  Cell Mol Life Sci       Date:  2011-07-09       Impact factor: 9.261

7.  Crystallization and preliminary X-ray crystallographic study of 1-deoxy-D-xylulose 5-phosphate reductoisomerase from Plasmodium falciparum.

Authors:  Tomonobu Umeda; Nobutada Tanaka; Yoshio Kusakabe; Masayuki Nakanishi; Yukio Kitade; Kazuo T Nakamura
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-02-25

8.  Structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in a quaternary complex with a magnesium ion, NADPH and the antimalarial drug fosmidomycin.

Authors:  Shunsuke Yajima; Kodai Hara; Daisuke Iino; Yasuyuki Sasaki; Tomohisa Kuzuyama; Kanju Ohsawa; Haruo Seto
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-05-31

Review 9.  Isoprenoid precursor biosynthesis offers potential targets for drug discovery against diseases caused by apicomplexan parasites.

Authors:  William N Hunter
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

10.  Conformational dynamics of the flexible catalytic loop in Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.

Authors:  Sarah L Williams; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2009-01       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.